Circulating Transcriptome Analysis Finds Gene Signatures and Immune Cell Activation and Abundance Predict Response to Immunotherapy in Bladder Cancer

Total RNA sequencing from whole blood provides high-quality data to predict clinical response, survival, and occurrence of irAE. The use of this type of sample before immune checkpoint blockage could improve treatment efficacy and irAE management.